Klaus Neef1,2, Yeong-Hoon Choi1,2, Sureshkumar Perumal Srinivasan1,2, Philipp Treskes1,2, Douglas B Cowan3, Christof Stamm4, Martin Rubach5, Roland Adelmann5, Thorsten Wittwer1,2, Thorsten Wahlers1,2. 1. Department of Cardiac and Thoracic Surgery, Heart Center of the University, University of Cologne, Cologne, Germany. 2. Center for Molecular Medicine, University of Cologne, Cologne, Germany. 3. Department of Pediatric Cardiology, Heart Center of the University, University of Cologne, Cologne, Germany. 4. Department of Anesthesiology, Perioperative and Pain Medicine, Children's Hospital Boston and Harvard Medical School, Boston, Mass. 5. Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany.
Abstract
OBJECTIVE: The effect of mechanical preconditioning on skeletal myoblasts in engineered tissue constructs was investigated to resolve issues associated with conduction block between skeletal myoblast cells and cardiomyocytes. METHODS: Murine skeletal myoblasts were used to generate engineered tissue constructs with or without application of mechanical strain. After in vitro myotube formation, engineered tissue constructs were co-cultured for 6 days with viable embryonic heart slices. With the use of sharp electrodes, electrical coupling between engineered tissue constructs and embryonic heart slices was assessed in the presence or absence of pharmacologic agents. RESULTS: The isolation and expansion procedure for skeletal myoblasts resulted in high yields of homogeneously desmin-positive (97.1% ± 0.1%) cells. Mechanical strain was exerted on myotubes within engineered tissue constructs during gelation of the matrix, generating preconditioned engineered tissue constructs. Electrical coupling between preconditioned engineered tissue constructs and embryonic heart slices was observed; however, no coupling was apparent when engineered tissue constructs were not subjected to mechanical strain. Coupling of cells from engineered tissue constructs to cells in embryonic heart slices showed slower conduction velocities than myocardial cells with the embryonic heart slices (preconditioned engineered tissue constructs vs embryonic heart slices: 0.04 ± 0.02 ms vs 0.10 ± 0.05 ms, P = .011), lower maximum stimulation frequencies (preconditioned engineered tissue constructs vs embryonic heart slices: 4.82 ± 1.42 Hz vs 10.58 ± 1.56 Hz; P = .0009), and higher sensitivities to the gap junction inhibitor (preconditioned engineered tissue constructs vs embryonic heart slices: 0.22 ± 0.07 mmol/L vs 0.93 ± 0.15 mmol/L; P = .0004). CONCLUSIONS: We have generated skeletal myoblast-based transplantable grafts that electrically couple to myocardium.
OBJECTIVE: The effect of mechanical preconditioning on skeletal myoblasts in engineered tissue constructs was investigated to resolve issues associated with conduction block between skeletal myoblast cells and cardiomyocytes. METHODS:Murine skeletal myoblasts were used to generate engineered tissue constructs with or without application of mechanical strain. After in vitro myotube formation, engineered tissue constructs were co-cultured for 6 days with viable embryonic heart slices. With the use of sharp electrodes, electrical coupling between engineered tissue constructs and embryonic heart slices was assessed in the presence or absence of pharmacologic agents. RESULTS: The isolation and expansion procedure for skeletal myoblasts resulted in high yields of homogeneously desmin-positive (97.1% ± 0.1%) cells. Mechanical strain was exerted on myotubes within engineered tissue constructs during gelation of the matrix, generating preconditioned engineered tissue constructs. Electrical coupling between preconditioned engineered tissue constructs and embryonic heart slices was observed; however, no coupling was apparent when engineered tissue constructs were not subjected to mechanical strain. Coupling of cells from engineered tissue constructs to cells in embryonic heart slices showed slower conduction velocities than myocardial cells with the embryonic heart slices (preconditioned engineered tissue constructs vs embryonic heart slices: 0.04 ± 0.02 ms vs 0.10 ± 0.05 ms, P = .011), lower maximum stimulation frequencies (preconditioned engineered tissue constructs vs embryonic heart slices: 4.82 ± 1.42 Hz vs 10.58 ± 1.56 Hz; P = .0009), and higher sensitivities to the gap junction inhibitor (preconditioned engineered tissue constructs vs embryonic heart slices: 0.22 ± 0.07 mmol/L vs 0.93 ± 0.15 mmol/L; P = .0004). CONCLUSIONS: We have generated skeletal myoblast-based transplantable grafts that electrically couple to myocardium.
Authors: Albert A Hagège; Claire Carrion; Philippe Menasché; Jean-Thomas Vilquin; Denis Duboc; Jean-Pierre Marolleau; Michel Desnos; Patrick Bruneval Journal: Lancet Date: 2003-02-08 Impact factor: 79.321
Authors: M Roselle Abraham; Charles A Henrikson; Leslie Tung; Marvin G Chang; Miguel Aon; Tian Xue; Ronald A Li; Brian O' Rourke; Eduardo Marbán Journal: Circ Res Date: 2005-06-23 Impact factor: 17.367
Authors: Frank Pillekamp; Michael Reppel; Vera Dinkelacker; Yaqi Duan; Nathalie Jazmati; Wilhelm Bloch; Konrad Brockmeier; Juergen Hescheler; Bernd K Fleischmann; Ruediger Koehling Journal: Cell Physiol Biochem Date: 2005
Authors: D A Taylor; B Z Atkins; P Hungspreugs; T R Jones; M C Reedy; K A Hutcheson; D D Glower; W E Kraus Journal: Nat Med Date: 1998-08 Impact factor: 53.440